A specific anti-IFITM2 antibody bars the way to SARS-CoV-2 entry into host cells.
A. Basile, C. Zannella, M. De Marco, G. Franci, M. Galdiero, G. Sanna, A. Manzin, M. Chetta, M. C. Turco, A. Rosati, L. Marzullo
This study identifies an anti-IFITM2 antibody that blocks SARS-CoV-2 entry into host cells and reduces cytopathic effects and syncytia formation.
bioRxiv · Aug 4, 2022Microbiology